Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502828713

Med Vet International Laverdia-Ca1 (Verdinexor) Tablets For Dogs 2.5mg, 50 Count

Supplier:  Med Vet International RXLAVERDIA2.5K9

Encompass_Preferred

Laverdia™-CA1 is the first oral tablet FDA conditionally approved to treat lymphoma in dogs. Verdinexor is a selective inhibitor of nuclear export CRM1/XPO1 protein The active ingredient in Laverdia-CA1 is verdinexor, a substance that works by preventing tumor suppressing proteins from leaving the nucleus of cells, resulting in disruption of cancer cell survival and eventual cancer cell death*Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-526.

Catalog No. 50-282-8713


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.